Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist.
Saved in:
| Title: | Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist. |
|---|---|
| Authors: | Nussbaum JC; Merck & Co., Inc., Rahway, New Jersey, USA., Hussain A; Merck & Co., Inc., Rahway, New Jersey, USA., Min KC; Merck & Co., Inc., Rahway, New Jersey, USA., Marbury TC; Orlando Clinical Research Center, Orlando, Florida, USA., Lasseter K; ERG Clinical, New Providence, New Jersey, USA., Stoch SA; Merck & Co., Inc., Rahway, New Jersey, USA., Iwamoto M; Merck & Co., Inc., Rahway, New Jersey, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2022 Nov; Vol. 62 (11), pp. 1435-1444. Date of Electronic Publication: 2022 Jul 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
